Dr. Omar’s lab works to understand neural circuits and to repair them using novel therapies. To do so, they use electrophysiology (in both humans and rodents), optogenetics, two-photon imaging and computational methods to study neuropsychiatric circuit dynamics. They are also experts at making sense of big data, focusing on new ways of understanding brain rhythms as biomarkers of disease progression. By collaborating with clinicians, they hope to work together to design new biophysically-inspired therapies for traumatic brain injury, epilepsy, post-traumatic epilepsy and post-traumatic depression.
Dr. Omar also teaches two newly designed courses: "Brain Rhythms in Cognition, Mental Health and Epilepsy" & "Introduction to Neural Circuits". The goal is to help to train the next generation of researchers and clinicians to use a detailed knowledge of neural circuits combined with quantitative techniques to study and treat neurological and psychiatric disorders.
Dr. Athey serves as the Michael A. Savageau Collegiate Professor and Founding Chair of the Department of Computational Medicine and Bioinformatics (DCM&B) at UM Medical School; and also a Professor of Psychiatry and Internal Medicine. Dr. Athey’s laboratories research is in the area of Psychiatric and Addiction Pharmacogenomics using bioinformatics, epigenomics, chromatin capture technology, and data mining from the U-M Health System Electronic Health Record (EHR). He also has a long record of imaging research, and has gotten back involved in this work, collaborating with Prof. Christopher Cremer at the University of Mainz, Germany. Dr. Cremer is a pioneer in super-resolution microscopy, and was the Ph.D. mentor of Professor Stephan Hell, recipient of the 2014 Nobel Prize for super resolution microscopy. Together they have an active program multiomics-based pharmacogenomics research, with major proposals being under review at DOC and being prepared for the FDA.
Dr. Athey serves as PI of the UM NIGMS T32 UM Bioinformatics Training Program (in year 12; funded to year 17). The department and his research are both deeply committed to bioinformatics, epigenomics, proteomics, metabolomics, and multi-scale ‘omics integration research. This focus is termed “Translational Bioinformatics” and the group is an acknowledged pioneer in this area. DCM&B hosts the well-established Bioinformatics Graduate Program (BGP), which has graduated 65 PhDs and over 40 MS trainees since 2005. In the 2017 academic year, there are >60 PhD and >20 MS trainees in the BGP. His department is also involved with Big Data research and development in Michigan Medicine, and on the UM Campus more generally, where he serves as Co-Director of the UM Data Science Initiative as Co-Director of the Michigan Institute for Data Science (MIDAS). Dr. Athey has served as a consultant to the Defense Science Office of DARPA and to the NIH Office of the Director and the NIH CIO. He has been a fellow of the Federation of American Scientists (FAS.org).
Dr. Athey has more than 15 years of experience in trans-disciplinary team science-based leadership experience as overall Principal Investigator of national and international biomedical informatics and computational sciences center and consortium leadership. These include the National Library of Medicine (NLM) Visible Human Project, the DARPA Telepathology Project and DARPA Virtual Solider Project, and the NIH National Center for Integrative Biomedical Informatics, NCIBI (see http://portal.ncibi.org/gateway/). In addition, he was the founding lead of the UM NIH Clinical and Translational Sciences Award (CTSA) Biomedical Informatics Core (BIC) of the Michigan Institute for Clinical and Health Research (MICHR) CTSA. He is the founding co-CEO of the tranSMART Foundation, and now serves as its Chief Science Officer. The tranSMART Platform is being used worldwide in data driven discovery research in clinical and translational research. This could allow the Center and its members to analyze multi-omics and clinical/phenotypic data in the same analytic platform and to share it with collaborators outside of UM. He currently has 3 PhD students and 1 postdoctoral scholar. He has trained or co-Mentored over 14 MS, 16 PhD, and 7 postdoctoral fellows who are all enjoying successful careers in academia, industry, and government service.
Ryan C. Bailey is the Robert A. Gregg Professor in the Department of Chemistry at the University of Michigan. He received degrees in chemistry from Eastern Illinois University (B.S.) and Northwestern University (PhD.), and completed postdoctoral training jointly at the California Institute of Technology and the Institute for Systems Biology. Prior to joining the faculty at Michigan, Prof. Bailey was on the faculty at the University of Illinois at Urbana-Champaign for a decade. His research group is generally interested in developing highly multiplexed and parallelizable detection strategies for point-of-care diagnostics, with applications in advanced genomic, transciptomic, proteomic, and epigenomic analyses. Prof. Bailey was named by Technology Review Magazine at a Top Innovator under 35 and has been recognized with a Sloan Foundation Fellowship, the Arthur F. Findeis Award from the American Chemical Society, and a NIH Director’s New Innovator Award, among others.
Dr. Besirli’s goal as a clinician-scientist is to improve vision in children and adults with retinal disorders and use the power of retinal imaging to diagnose and treat ocular and systemic diseases. He specializes in diseases and surgery of the retina and vitreous as well as management of acquired and inherited pediatric retinal disorders. He has had extensive medical and surgical training in vitreoretinal disorders, including retinal dystrophies and complex adult and pediatric vitreoretinal surgery.
A great majority of his time is spent reviewing retinal images of patients with various ocular and systemic diseases. Ophthalmology benefits from cutting-edge imaging technologies that allow him to view neuroretina and retinal microvasculature directly, providing exquisite diagnostic information that no other non-invasive imaging technology can match.
As a basic research scientist, his laboratory studies the molecular mechanisms of apoptosis and survival during periods of neuronal and retinal stress. His PhD training in neuronal apoptosis and post-PhD work in photoreceptor cell death has provided him with a unique expertise in designing, executing and analyzing cell death and survival assays in different experimental paradigms, including various cell lines and in vivo models of neuronal and retinal diseases in rodents. He has used these models extensively to identify small molecule inhibitors of apoptosis in cell lines, primary neurons, and photoreceptors. A small peptide inhibitor of photoreceptor neuron apoptosis he developed during his ophthalmology training is now in early development to become the first successful neuroprotective agent in the eye.
Dr. Besirli’s laboratory is currently working towards understanding how neuronal cells regulate energy metabolism and activate survival or death pathways using retina as a model tissue.
Dr. Bodary has a BS in Health Sciences, a MS in Health Promotion and Human Performance and a PhD in Exercise Physiology. He has subsequently spent ~ 10 years (as post-doc and junior faculty member) working with mouse models of cardiovascular disease complications (most commonly arterial thrombosis and atherosclerosis). Dr. Bodary has most recently been serving as clinical faculty in the UM School of Kinesiology where he is involved in teaching at all academic levels and performing research with colleagues across campus including Michigan Athletics and Michigan Medicine. He is passionate about the use of technology and data to improve patient health and human performance.
The Burke Laboratory research effort is concentrated in three main areas: (1) quantitative trait analysis of complex, multigenic traits in synthetic populations of the laboratory mouse, (2) the development of engineering systems for microfluidic analysis, and (3) low cost technology systems for health care delivery.
The first research area is a collaborative effort with other investigators at the University of Michigan to identify regions of the mouse genome correlated with inter-individual variation in complex adult phenotypes. Several phenotypic measures are examined in parallel, including body mass, T-cell populations, circulating hormones, bone structure, late-life hearing loss, and cancer incidence. We have identified gene locations associated with several late-life phenotypes, using a reproducible, genetically heterogeneous laboratory mouse "synthetic" population. The second project is a collaborative effort with Dr. Mark Burns (University of Michigan, Department of Chemical Engineering), and is developing a high-throughput DNA genotype analysis systems that can be provided to researchers and clinicians at low cost. The microfluidic devices: a) require human interaction only for initial loading of samples, b) provide consistent experimental processing and quality control, c) decrease sample processing time and human labor, d) reduce reagent costs by reducing the genotyping biochemistry to nanoliter volumes, and e) be fully controlled by integrated circuitry. The third area of work is a newly established cross-disciplinary research effort that will attempt to bring low cost technologies to clinics and clinical researchers. The focus is on developing advanced technologies that are readily manufactured, robust, and distributed.
Dr. Burke is a graduate of the University of Rochester (BS, Biological Sciences) and Washington University in St. Louis (PhD, Genetics). He has been a faculty member in the Department of Human Genetics since 1991.
Dr. Cohn is an Associate Professor in the Department of Industrial and Operations Engineering (IOE) in the University of Michigan College of Engineering. She holds a dry appointment in the School of Public Health Department of Health Management and Policy as well. In 2011, she was named an Alfred F. Thurnau Professor, the University's highest award for undergraduate teaching. She is also Associate Director of the Center for Healthcare Engineering and Patient Safety, as well as an Affiliate of the MIT Global Airline Industry Program.
In 1991, Dr. Cohn received the A.B. in Applied Mathematics, magna cum laude, from Harvard University. She was awarded the PhD in Operations Research from the Massachusetts Institute of Technology in 2002 and then joined the University of Michigan. Her primary research focus is on large-scale applied combinatorial optimization problems in complex systems. Her initial focus was on passenger aviation. She continues to work extensively in this field, but has shifted over the past five years to an increasing focus on health applications, and frequently draws parallels within her research between these two application domains.
In 2011, the College of Engineering and the School of Medicine jointly launched the Center for Healthcare Engineering and Patient Safety (CHEPS), naming Dr. Cohn as the Associate Director with a focus on developing the infrastructure to support research and educational activities spanning medicine and engineering. The mission of CHEPS is to "improve the safety and quality of healthcare delivery through a multi-disciplinary, systems engineering-based approach."
As part of this mission; Dr. Cohn has developed an annual fall seminar series (open to the public as well as to students for credit under course number IOE813) that presents innovative research by teams comprised of engineering and clinical faculty working in partnership. This series enrolls students for credit from engineering, public health, nursing, business, and other units, as well as drawing an audience from engineering, nursing, medicine, public health, public policy, and members from the outside community. Dr. Cohn has also launched a new masters concentration in Healthcare Engineering and Patient Safety (HEPS) within the IOE graduate program, and is in the process of expanding this to be a multi-unit degree program.
This activity is demonstrative of Dr. Cohn's commitment to education at all levels. She has been recognized in many ways for this commitment, including being named an honorary member of both the Alpha Pi Mu and Tau Beta Pi student honor societies, being voted IOE Professor of the Year by students six times in the last eleven years, being given the Holt Award for Excellence in Teaching three times, and being named as the University of Michigan's nominee for the state-wide Michigan Distinguished Professor of the Year award.
Dr. Cohn's current and recent collaborative research projects include work in: predicting surges in the adult emergency department; reducing the length of stay for children with asthma in the pediatric emergency department; improving the safety and efficiency of outpatient chemotherapy infusion; and developing scheduling tools for medical residents to increase their access to key training opportunities (e.g. heart and lung transplant experience) and to improve schedule quality (e.g. through reductions in disruptive sleep patterns within shift schedules) to in turn improve quality of life, quality of patient care, and quality of educational experience.
Dr. Cohn devotes the remainder of her time to her family -- her son Tommy is an avid Red Sox fan and self-proclaimed "science nerd"; her son Peter divides his time between art and gymnastics; and her husband, Jonathan Cohn, is a journalist for The New Republic who focuses on healthcare and other domestic policy issues.
Dr. Louis G. D’Alecy is a Professor of Physiology in the Department of Molecular and Integrative Physiology and the Director of the Telemetry Core Facility. As the Sequence Director for the Cardiovascular and Respiratory Sequences for first year medical students, he spends a lot of time in the classroom in addition to his research in the broad area of cardiovascular physiology and medicine specific to vivo and in-vitro experimentation.
Dr. D’Alecy’s research focus is on the vascular system to better understand how blood vessels and blood flow are controlled in health and in disease. New chemicals and pathways are identified every day as contributors to cardiovascular risk that make heart and vascular disease a leading cause of morbidity and mortality. While “special circulations” such as the brain (cerebral) and heart (coronary) receive the greatest attention from both clinicians and researchers, Dr. D’Alecy looks to the generality of vascular disease that can cripple or incapacitate virtually any tissue or organ in the body be it a painful cramp in a leg or a failing kidney. Dysfunction of blood flow control systems tend to have common elements and by uncovering the generalizable basic control systems and their failures, the potential for a more holistic good for the cardiovascular system may be obtained.
Dr. Davenport received his undergraduate degree from the California Institute of Technology, Pasadena, California in 1977, his M.A. from the University of California, Berkeley, California in 1979, and MD degree from the University of Michigan in 1984. He completed residency training in Anatomic and Clinical Pathology at the University of Michigan in 1988. Subsequently, Dr. Davenport took fellowship training in Cytopathology, and in Blood Banking and Transfusion Medicine, both at the University of Michigan. He is a Diplomate of the American Board of Pathology (Anatomic and Clinical Pathology) and holds ABP Subspecialty Certification in Blood Banking and Transfusion Medicine.
Dr. Davenport joined the faculty of the University of Michigan Department of Pathology when he was appointed a Lecturer in 1989, an Assistant Professor in 1990, and an Associate Professor in 1997. His principal clinical interests are in appropriate blood transfusion practice, therapeutic apheresis, and adverse effects of blood transfusion. His major research interests are in the role of cytokines in transfusion reactions, immunomodulation by blood transfusion, and transfusion transmitted diseases.
Harm Derksen is a Professor within the Mathematics Department at the University of Michigan. His pure math research is in commutative and non-commutative algebra, combinatorics and number theory. His particular areas of interest are Invariant Theory and Representation Theory of Quivers. His applied math research is on tensors, big data, signal processing and machine learning. He is currently working on methods for processing biomedical signals.
Harm Derksen graduated from the University of Nijmegen (BS mathematics) in 1993 and received his PhD in mathematics in 1997 from the University of Basel. He was a postdoctoral researcher at Northeastern University and MIT before joining the faculty at the University of Michigan in 2000.
Dr. Gonzalez holds a Ph.D. in Psychology from Stanford University and a BA in Psychology from UCLA. He directs a new center, the Biosocial Methods Collaborative, at the University of Michigan on the development of methods for the integration of biological and social science data. In addition to his faculty positions at the University of Michigan at the Institute for Social Research, the Center for Human Growth and Development, Psychology and Marketing, he has been on the faculty of the University of Washington and a visiting professor at Princeton University.
Dr. Gonzalez’s main research areas are methodology and judgment/decision making. He develops mathematical models for psychological processes in decision making and has been exploring the role of emotions in decision making. He makes use of mathematical models that integrate multiple intra individual processes that span multiple levels of analysis from biological to psychological to cultural. His research in statistics has focused on nonparametric statistics, generalized linear (and nonlinear) mixed models, multivariate multilevel models, which include longitudinal designs, latent transition models and dyadic models, model-based classification methods such as latent class and mixture models, exploratory techniques such as classification and regression trees and machine learning classification techniques, and data visualization. Dr. Gonzalez works in both classical and Bayesian frameworks.
Peter F. Green is the Vincent T. and Gloria M. Gorguze Professor of Engineering and Professor of Materials Science and Engineering, University of Michigan, Ann Arbor. He also holds positions in Applied Physics, Chemical Engineering and Macromolecular Science and Engineering. He began his career at Sandia National Laboratories in 1985 and was Manager of Glass and Electronic Ceramics Research from 1990-1996. In 1996 he moved to the University of Texas Austin where he became Professor of Chemical Engineering and was the BF Goodrich Endowed Professor of Materials Engineering. In 2005 he moved to the University of Michigan.
Professor Green was the 2006 President of the Materials Research Society (MRS). He is a Fellow of the Royal Society of Chemistry (London); Fellow of the American Physical Society and a Fellow of the American Ceramics Society. He served as a Divisional Associate Editor for Physical Review Letters, 2000-2006. He has served on advisory boards for the National Research Council, National Institutes of Standards and Technology, Sandia National Laboratories and Universities.
Green’s interests include transport phenomena, interfacial phenomena, morphological transitions and self-assembly in soft matter. He earned his Master of Science and Doctorate in Materials Science and Engineering from Cornell University on 1985, and his MA and BA degrees in Physics from Hunter College, N.Y in 1981.
Myron Hepner is the Sr. Director for Data, Reporting, and Analytics in Michigan Medicine Health Information Technology & Services (HITS). He is also the Director of the Michigan Data Collaborative.
Myron is a healthcare information professional with expertise in healthcare data, application development, reporting, analytics, team management, and performance support, with over 20 years leading data asset creation and information technology teams in the healthcare industry. He has been with the University of Michigan over 11 years, the last 6+ of which have been with health system. Prior to joining the University of Michigan, Myron worked at IBM, Accenture, MEDSTAT, and StatProbe.
Myron is a graduate of the University of Michigan College of Engineering, and a lifelong, True Blue, Michigan Man. He is a resident of Ann Arbor and father of two – Brendan (14 years old) and Caitlyn (13 years old). He enjoys running, family time, reading, and road trips in his spare time, and hosts an annual fundraiser (called March Hoops to BEAT Blindness) to support research at the Kellogg Eye Center.
Dr. Higgins has served in corporate, hospital, federal and academic research settings. He has 2 doctorates and an MD (psychiatry), but does not practice medicine. He has served as Chief of Molecular Neurobiology at the National Institutes of Health (NIND; NIA), U.S. VP of R&D for Roche, CMIO at MedStar Health (9 hospitals including Georgetown and Washington Hospital Ctr), IPA at the Defense Advanced Research Projects Agency (DARPA), and most recently as VP of Pharmacogenomics at Assurex Health, now a subsidiary of Myriad Genetics. He also co-founded SimQuest International, served as President and CEO, and sold the company to Laerdal Medical Corporation. He has received both federal grants and contracts (24), and raised substantial private equity funding. He has over 200 peer-reviewed publications.
Jeannette Jackson is the Managing Director of the BioSocial Methods Collaborative located at the Institute for Social Research. Jeannette holds her MBA from the University of Michigan and her BA from Smith College. Her background is in organizational change and leadership development and she came to this position after running (with a partner) a consulting firm specializing in non profit management and leadership development.
Phil Jacokes is a highly seasoned executive with a strong background in operations leadership and cutting-edge software/technology products, with first-hand experience in successfully starting, building and growing profitable organizations. A proven, collaborative leader and entrepreneur with over 20 years of experience, Phil is ready to apply his expertise, skills and creative problem solving to help take MCIRCC to the next level. Phil earned his MBA from Wayne State University and is a U-M alum where he received his BA in Communication.
Dr. Keteyian is a healthcare professional with diverse experiences. He completed a medical innovation fellowship at the University of Michigan, which strives to educate leaders in biomedical innovation. This experience cultivated an interest in accelerating the commercialization of promising technologies that improve patient care. His current research focuses on the potential of wearable technologies to revolutionize the delivery environment. The future state of healthcare will benefit from technologies able to improve health, anticipate sickness, and augment or replace many of the activities currently performed by healthcare providers. He is active in the local entrepreneurial community, and enjoys mentoring aspiring innovators in the engineering, medical, and business schools.
Dr. Keteyian also works in the University of Michigan Health System’s Strategic Finance and Business Consulting group, which is responsible for an array of institutional projects, and ensures high value business solutions are planned and executed. Healthcare reform efforts created a dynamic environment for academic health systems, and Dr. Keteyian focuses on framing strategic clinical expansion activities and innovative service delivery models. Dr. Keteyian completed a medical internship in emergency medicine. He holds both his M.D. and M.B.A. degrees from the University of Michigan, and a B.S. in Molecular, Cellular, and Developmental Biology from Yale University.
Dr. Kovelman’s research interests are in language and reading development in monolingual and bilingual infants, children, and adults. Her work includes both typical and atypical language and reading development using a variety of behavioral and brain imaging methods (fMRI, fNIRS).
Dr. Steven Kunkel is the Endowed Professor of Pathology Research, Head of the Immunology Program, and Senior Associate Dean for Research at the University of Michigan Medical School. He received his PhD at the University of Kansas in microbiology and did his post-doctoral training at the University of Connecticut Health Sciences. His areas of research have centered on assessing molecular mechanisms of lung inflammation by investigating cytokine directed cell-to-cell communication circuits. A significant amount of this work helped to launch and define the field of chemokine biology. In addition, he has been involved in assessing epigenetic regulation of immune cell phenotypes which dictate the expression pattern of inflammatory mediators. His studies in cytokine and chemokine biology are internationally recognized and have provided a more clear understanding of how these proteins are regulated and participate in the initiation, maintenance, and resolution of acute and chronic lung diseases. He has co-authored600 peer reviewed manuscripts, has an H-Index of greater than 100, possesses 12 patents, and has maintained continuous funding of major National Institute of Health grants for over 3 decades years. In his current administrative role, as the Senior Associate Dean for Research in the Medical School, he oversees both basic and clinical research in the Medical School. He has served on numerous National Institute of Health peer review study sections, organized a variety of international conferences on inflammation (organized Gordon and Keystone Conferences), is an associate editor for various professional scientific journals, and is a past recipient of an NIH MERIT Award. In addition, he is the former chair of the Board of Scientific Counselors for the NIAID-NIH, a member of the American Society for Clinical Investigation, and a fellow of the American Association for the Advancement of Science.
Dr. Kenichi Kuroda is an Assistant Professor in the Department of Biologic and Materials Sciences, School of Dentistry at the University of Michigan. He also has appointments in Chemistry, Biomedical Engineering, and Macromolecular Science and Engineering Center. He received his B. Eng. in Polymer Chemistry and M. Eng. in Biological Chemistry from Kyoto University, Japan. He earned his Ph.D. in Physical Chemistry from MIT in 2003. Prior to joining the faculty at the University of Michigan in 2006, he was a postdoctoral researcher at University of Pennsylvania School of Medicine.
Dr. Kuroda’s research interests include the development of simple, cost-effective, and versatile antimicrobial materials based on synthetic polymers to strengthen our arsenal in the fight against drug-resistant bacteria “superbugs”. His current research focuses on a new molecular design of antimicrobial polymers as synthetic mimics of naturally occurring host-defense antimicrobial peptides in the innate immune system. His laboratory also works on the antimicrobial/anti-fouling polymer coatings to prevent biofilm formation on medical plastics. In addition to the synthesis of new materials, his research approach also uses biophysical and physicochemical methods to deepen our understanding on the polymer-bacteria interactions at the molecular level to discover a new mode of antimicrobial action for pharmaceutical and biotechnological applications. Kuroda’s work has been funded by the NIH (NIDCR), NSF (DMR), Michigan Institute for Clinical & Health Research (MICHR), and Michigan Universities Commercialization Initiative (MUCI).
Dr. Kuroda currently serves as a member of Associate Editorial Board of Journal of Bioactive and Compatible Polymers. He reviews for numerous journals in polymer science and engineering and biomaterials. He received NSF Career Award (Biomaterials).
Mark E. Meyerhoff is currently a Philip J. Elving Professor of Chemistry in the Department of Chemistry. He received his Ph.D. from the State University of New York at Buffalo in 1979, working with Professor Garry A. Rechnitz. Following a short post-doctoral stint at the University of Delaware (also with Prof. G. A. Rechnitz), he joined the faculty at Michigan as an Assistant Professor in the fall of 1979. He was promoted to associate professor in 1985, and to full professor in 1990.
Professor Meyerhoff’s primary research interests are in the field of analytical chemistry, particularly the development of new ion-, gas-, and bio-selective electrochemical/optical sensors suitable for direct measurements of clinically important analytes in physiological samples. He also has a very active research program in the area of biomaterials, especially the development and characterization of novel nitric oxide (NO) releasing/generating polymeric materials for biomedical applications. These advanced NO release materials are being examined as potent antithrombotic and bactericidal coatings for a wide range of medical devices. He and his collaborators have authored more than 350 original research papers on these and other topics over the past 36 years since beginning his independent academic career at Michigan. His research has been funded by a series of grants from the National Institutes of Health (dating back to 1981) and other agencies/foundations.
Professor Meyerhoff received the University of Michigan’s Faculty Recognition Award in 1990, was elected as a Fellow by the National Academy of Clinical Biochemistry in 2002, received the ACS-Division of Analytical Chemistry Award in Electrochemistry in 2003, the Society for Electroanalytical Chemistry’s Reilley Award in 2006, The University of Michigan’ Outstanding Graduate Mentoring Award in 2006, the University of Michigan’s Distinguished Faculty Achievement Award in 2011, and the Ralph Adams Award in Bioanalytical Chemistry from the Pittsburgh Conference on Analytical Chemistry in 2014. He has served or currently serves on the editorial/advisory boards of Analytical Chemistry, Clinical Chemistry, Electroanalysis, Analytica Chimica Acta, Mikrochimica Acta, and Biosensors and Bioelectronics. He is also active as a consultant and/or is on the Scientific Advisory Boards of several biomedical companies including Instrumentation Laboratory, I-SENS, EyeLab, Biocrede, and Selective Technologies, Inc. Previously, he served as consultant to Dow, Abbott Laboratories, Sensicore, Mallinkrodt Medical, Eli Lilly, Bolton Medical, Medtronic, Angioscore, Michigan Critical Care Consultants, and GDS Technologies.
Dr. Nemzek is an Assistant Professor in the Unit for Laboratory Animal Medicine (ULAM) at the University of Michigan. She received her DVM from University of Minnesota in 1987, completed an internship at the University of Illinois in 1989 and finished residency training in surgery at Michigan State University (MSU) in 1992. After clinical training, she remained at MSU to complete a Masters in Clinical Sciences and a research fellowship focusing on development of an animal model of retroviral transmission in connective tissue transplantation. She joined the University of Michigan in 1997 to pursue a T32 funded postdoctoral fellowship in Comparative Medicine. As a faculty member, she was awarded a K08 to study the role of chemokines in sequential inflammatory insults within ULAM and the Department of Pathology/.
Dr. Nemzek’s research studies focus on the innate immune effects of trauma, sepsis and acute lung injury. Her current NIH funded studies have identified a novel cell therapy for sepsis that enhances T cell proliferation through an antigen-independent mechanism. In addition, she has received funding from the American Association of Laboratory Animal Science and the American College of Laboratory Animal Medicine Foundation to pursue practical welfare refinements that maintain the scientific integrity of murine sepsis models. For these studies, she was the recipient of the AALAS Nathan R. Brewer Scientific Achievement Award.
In her current position, Dr. Nemzek is the supervisor of the ULAM-Animal Surgery Operating Rooms, providing veterinary as well as business management oversight. She reviews for several journals spanning human and veterinary medical research in surgery and critical care. She actively participates in the clinical, research and didactic training of the 12 veterinary residents at University of Michigan. As an adjunct faculty member of MSU, she coordinates experiential programs in research for professional students and has a strong commitment to promoting alternative careers for veterinarians in biomedical research
Kathryn is a doctoral student in the School of Kinesiology. She graduated from the College of the Holy Cross where she played ice hockey and graduated with a Bachelor of Arts in Psychology in 2010. Within the NeuroTrauma lab, she primarily works on the Longitudinal Clinical Study Core of the Concussion, Assessment, Research and Education (CARE) Consortium project. Her research interests include the susceptibility to concussion in both athlete and military populations, biomechanics, and traumatic brain injury assessment.
Prior to arriving at the University of Michigan she worked in the Neurosciences Intensive Care Unit at Massachusetts General Hospital. Using electroencephalography (EEG), her research focused on the utility of EEG as a non-invasive monitoring device for aneurysmal subarachnoid hemorrhage and severe traumatic brain injured patients.
Carleen Penoza has a Master's in Health Services Administration and a Bachelor of Science in Nursing, both from the University of Michigan. Carleen began her career in the Pediatric Intensive Care Unit at Beaumont Health System in 1994. She worked as a staff nurse, transport nurse, preceptor, and associate nurse manager within the Pediatric Intensive Care Unit. In 2004, she took a position as a Clinical Informatics Specialist at Beaumont, Royal Oak. She formed the department of Clinical Informatics and assisted in the implementation of Epic at all three of the Beaumont Health System hospitals as the Director of Clinical Informatics. After the implementations, she took on the role of System Director of Clinical Informatics and EHR Optimization for Beaumont Health System. When Beaumont Health System affiliated with other organizations to become Beaumont Health, Carleen was asked to lead the implementation of Epic at the Botsford Hospital.
Carleen took a new position as the Director of Inpatient Applications at the University of Michigan Health System in 2015. She currently supports the OB, Clinical Documentation, ED, Orders, Med Use Informatics, Med Use Technology, and OR team at UMHS.
Dr. Deborah M Rooney is the Director of Education and Research for the Clinical Simulation Center of University of Michigan Medical School. Dr. Rooney holds a doctorate in Educational Psychology (MESA: Measurement, Evaluation, Statistics, and Assessment) from University of Illinois at Chicago, and has over twenty years’ experience in medical education. Since 2004, Dr. Rooney’s work has focused on simulation-based education, with a primary focus on assessment and measurement. Her current research focuses on innovation and evaluation of novel simulation-based curricula and simulators. One particular area of interest is validation of novel simulators using modern measurement theory. Dr. Rooney is an active member of a number of education and simulation and healthcare associations. These include American Educational Research association (AERA), National Council on Measurement in Education (NCME), Association of Surgical Education (ASE), and American College of Surgeons (ACS), and Society for Simulation and Healthcare (SSHIH). She was a founding member of the Administration and Management Committees for the ASE and ACS, respectively, and currently sit on the Technology & Simulation Committee for the ACS.
Sara E. Samborn is a Registered Nurse who serves as the Michigan Trauma Quality Improvement Program Clinical Reviewer.
Ms. Samborn received her Bachelor of Science in Psychology from Eastern Michigan University in 2003. In 2007, she completed her Master of Science in Nursing at the University of Toledo, and attained a Graduate Certificate in Medical Informatics for Clinicians from Northwestern University in 2015. Ms. Samborn is a member of the Society of Trauma Nurses.
Dr. Singh is a Professor of Computer Science & Engineering at the University of Michigan where he also currently serves as the Director of the Artificial Intelligence Laboratory. He received his PhD in Computer Science from the University of Massachusetts, Amherst, following a B.Tech. in Electrical Engineering from the Indian Institute of Technology, New Delhi, India. He joined the University of Michigan in 2002 after a Postdoctoral Fellowship in Brain and Cognitive Sciences at Massachusetts Institute of Technology, a Scientist position at Harlequin Inc., an Assistant Professorship at University of Colorado, Boulder, a Senior Research Scientist position at AT&T-Labs Research, and a Chief Scientist position at a venture capital company (Systek Capital).
Dr. Singh’s research interests focus on the field of Reinforcement Learning, i.e., on building algorithms, theory, and architectures for software agents that can learn how to act in uncertain, complex, and dynamic environments. Specific interests include building models of dynamical systems from time-series data, learning good interventions in human-machine interaction, dealing with partial observability and hidden state in sequential decision-making, dealing with the challenge of exploration-exploitation and delayed feedback, explaining animal and human decision making using computational models, and optimal querying in semi-autonomous agents based on value of information. He is interested in applications from healthcare, robotics, and game-playing. He is a Fellow of the Association for the Advancement of Artificial Intelligence, has received an outstanding faculty award from his department, and has published over 100 papers in his field.